1.
Muñoz-Cerón J, Rodríguez I, Guerra C, Vélez K, Hernández N, Nieto-Rodríguez P, Barrera DG. Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC. Headache Med [Internet]. 2025 Mar. 30 [cited 2025 Apr. 4];16(1):65-70. Available from: https://headachemedicine.com.br/index.php/hm/article/view/1340